Академический Документы
Профессиональный Документы
Культура Документы
Address: 1Apoteket AB, and School of Pure and Applied Natural Sciences, University of Kalmar, Kalmar, Sweden and 2e-Health Institute, School
of Human Sciences, University of Kalmar, Kalmar, Sweden
Email: Bengt Åstrand* - bengt.astrand@hik.se; Emelie Montelius - emelie.montelius@hik.se; Göran Petersson - goran.petersson@hik.se;
Anders Ekedahl - anders.ekedahl@apoteket.se
* Corresponding author
Abstract
Background: The introduction of electronic transfer of prescriptions (ETP) or ePrescriptions in
ambulatory health care has been suggested to have a positive impact on the prescribing and
dispensing processes. Thereby, implying that ePrescribing can improve safety, quality, efficiency, and
cost-effectiveness. In December 2007, 68% of all new prescriptions were transferred electronically
in Sweden. The aim of the present study was to assess the quality of ePrescriptions by comparing
the proportions of ePrescriptions and non-electronic prescriptions necessitating a clarification
contact (correction, completion or change) with the prescriber at the time of dispensing.
Methods: A direct observational study was performed at three Swedish mail-order pharmacies
which were known to dispense a large proportion of ePrescriptions (38–75%). Data were gathered
on all ePrescriptions dispensed at these pharmacies over a three week period in February 2006. All
clarification contacts with prescribers were included in the study and were classified and assessed
in comparison with all drug prescriptions dispensed at the same pharmacies over the specified
period.
Results: Of the 31225 prescriptions dispensed during the study period, clarification contacts were
made for 2.0% (147/7532) of new ePrescriptions and 1.2% (79/6833) of new non-electronic
prescriptions. This represented a relative risk (RR) of 1.7 (95% CI 1.3–2.2) for new ePrescriptions
compared to new non-electronic prescriptions. The increased RR was mainly due to 'Dosage and
directions for use', which had an RR of 7.6 (95% CI 2.8–20.4) when compared to other clarification
contacts. In all, 89.5% of the suggested pharmacist interventions were accepted by the prescriber,
77.7% (192/247) as suggested and an additional 11.7% (29/247) after a modification during contact
with the prescriber.
Conclusion: The increased proportion of prescriptions necessitating a clarification contact for
new ePrescriptions compared to new non-electronic prescriptions indicates the need for an
increased focus on quality aspects in ePrescribing deployment. ETP technology should be
developed towards a two-way communication between the prescriber and the pharmacist with
automated checks of missing, inaccurate, or ambiguous information. This would enhance safety and
quality for the patient and also improve efficiency and cost-effectiveness within the health care
system.
Page 1 of 8
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
Figure in
Trends 1 transferred ePrescriptions in Sweden where the first ePrescription was launched in 1983 [16]
Trends in transferred ePrescriptions in Sweden where the first ePrescription was launched in 1983 [16]. In
December 2007, 68% (inter-county range 46–85%) of all prescriptions were electronically transferred with a steadily growing
trend.
Page 2 of 8
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
scriptions (unpublished observations Apoteket AB, the physicians' prescribing habits. Pharmacies in Sweden
December, 2007). A national ePrescription communica- do not have access to automated software for prospective
tion exchange hub with a virtual repository, called the drug utilization reviews (pDUR). For example, drug inter-
national mail box for prescriptions, allows the patient to actions and contraindications [23-25]. All prescriptions in
access their prescriptions at any pharmacy on presentation the present study were manually examined by the phar-
of valid identification. macists.
However, the introduction of new technologies such as Inclusion and exclusion criteria
ePrescribing may create new errors, both systematic and The study included prescriptions with prescription errors,
non-systematic, in the prescribing and dispensing proc- ambiguities, or other problems related to drug prescrip-
esses [19,20]. Stored ePrescription information may be tions for humans with a Swedish civic number where the
used not only for filling the actual prescription but also pharmacist judged it necessary to make a contact with the
for future clinical decision making and epidemiological prescriber prior to dispensing for clarification, correction,
research. Thus, it is vital to systematically monitor the completion, or change. All attempts to contact the pre-
quality of the electronic prescribing process [21,22]. scriber were included in the study regardless of whether
they resulted in a contact during the study period. Pre-
Aim of the study scriptions for non-pharmaceuticals (syringes, compres-
The aim of the present study was to assess the quality of sion stockings, dressings) or for animals were excluded.
ePrescriptions by comparing the proportions of ePrescrip-
tions and non-electronic prescriptions necessitating a clar- Definition of ePrescriptions
ification contact (correction, completion or change) with ePrescriptions were defined as personal prescriptions of
the prescriber at the time of dispensing. drugs for humans electronically transferred from the pre-
scriber's computer system to a national ePrescription mail
Methods box which is accessible to all Swedish pharmacies. At the
Type of study time of the study, ePrescriptions with refills were handled
The study was a prospective, direct, observational study. and recorded as ePrescriptions only at the first dispensing
Data was collected by trained observers (pharmacy stu- occasion. Prescriptions faxed or merely printed on paper
dents) using a specifically designed protocol. Ethical by a computer system were not defined as ePrescriptions.
approval was not sought for the study.
Work organization
Study period At all three settings, prescriptions were prepared in a two-
The study was conducted over a three week period (15 step process. Prescribing problems detected in the pre-
weekdays) in February–March 2006 at three mail-order scription preparation line were transferred to a second
pharmacies (MOP) in Sweden. line where a pharmacist at a phone desk was available to
investigate the problem and make contact with the pre-
Setting scriber if clarification was required. Some of the prescrip-
Four Swedish MOPs were invited to participate and one tion problems may have been resolved by the pharmacists
MOP subsequently declined. The three remaining MOPs themselves after consulting the patient or the patient's rel-
were chosen as study settings as they all handle prescrip- atives by phone or by means of other information sources.
tions for non-pharmacy outlets (about 900) in remote All contacts with the prescribers were made by the phar-
areas. In addition, they serve pharmacy customers directly macist at the phone desk. The prescribers were not noti-
via mail-order. Non-pharmacy outlets are general food fied of the study.
stores and other establishments that are not staffed by
pharmacists. They deliver pharmaceuticals in sparsely Data collection
populated areas as representatives for the pharmacies. The The observers closely followed the pharmacists at the
MOPs also had a relatively large proportion (range 38– phone desk, recording all attempts to make contact with
75%) of ePrescriptions at the time of the study. The same prescribers. A copy of the prescription was attached to the
regulations and operating procedures apply to the MOPs protocol form (See Additional file 1). The observations
as to the other community pharmacies (about 900) in were recorded and classified according to an internation-
Sweden. However, unlike their colleagues at other phar- ally developed protocol which was translated into Swed-
macies, pharmacists at the mail-order pharmacies cannot ish and modified for the Swedish context [26,27].
communicate with the patient 'face-to-face' at the phar-
macy counter. In addition, since they handle prescriptions Validation of classification
from prescribers who may not be in the same neighbor- Examination and supervision of the data classification
hood, they generally do not have personal knowledge of were performed by one of the authors (AE). Any irregular-
Page 3 of 8
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
ities in classification were discussed with the observers to Of the 31225 dispensed prescriptions, 1.0% (312/31225)
achieve consensus and consistency. necessitated a clarification contact with the prescriber.
These comprised 1.6% (226/14365) of all new prescrip-
Statistics tions and 0.5% (86/16860) of all refill prescriptions. This
The collected data were transferred to electronic form in yielded an RR of 3.1 (95% CI 2.4–4.0) for new prescrip-
Microsoft Access® and then exported to Microsoft Excel® tions compared to refill prescriptions (Table 2).
for cross tabulation.
The prescribers accepted 89.5% of the suggested pharma-
The outcome measures (numbers and frequencies of pre- cist interventions, 77.7% (192/247) as suggested and an
scriptions necessitating a clarification contact, causes of additional 11.7% (29/247) after a modification by the
clarification contacts, time and results of interventions) prescriber during the contact (Table 3). Each prescription
were related to statistics on dispensed prescriptions necessitating a contact with a prescriber contains one or
obtained from Apoteket AB (personal communication B- more interventions.
M Alsén) for February 2006 for the three pharmacies stud-
ied. These statistics were adjusted for number of workdays When new and refill prescriptions were pooled together,
(15/20) as the study covered a different time period (15 the median recorded duration of a contact with a pre-
workdays) to the collected statistics (20 workdays). Rela- scriber was lower for ePrescriptions (4 minutes) com-
tive risks (RRs) with 95% confidence intervals (95% CIs) pared to non-ePrescriptions (5 minutes).
were used to compare rates between the two groups ePre-
scriptions and non-ePrescriptions. RRs and 95% CIs were Discussion
calculated using Episheet http://ken.rothman.name. New ePrescriptions were associated with clarification con-
tacts to a greater extent than new non-electronic prescrip-
Results tions. This was mainly due to missing or ambiguous
The statistics for dispensed drug prescriptions during the information for 'Dosage and directions for use'. This may
month of February 2006 (adjusted for 15/20 workdays) be due to the widespread use of abbreviations, such as
comprised 41634 (adjusted to 31225) prescriptions. '1t3d' (one tablet three times daily) which have not been
46.0% consisted of new prescriptions (inter-pharmacy standardized among different EHRs. The abbreviations
range 42.8–50.0%). Of these new prescriptions, 52.4% may be translated by the EHRs in such a way that was
(inter-pharmacy range 38.0–74.6%) were transferred as unanticipated by the prescribers prior to transferring the
ePrescriptions (Table 1). prescription to the pharmacy. As only one in a hundred
prescriptions necessitated a prescriber contact, ePrescrip-
Clarification contacts were made for 2.0% (147/7532) of tions might still be more efficient and cost-effective over-
new ePrescriptions and 1.2% (79/6833) of new non-elec- all compared to non-electronic prescriptions. However, if
tronic prescriptions. This resulted in an RR of 1.7 (95% CI the potential of ePrescriptions is to be fulfilled, quality
1.3–2.2) for new ePrescriptions compared to new non- aspects must be more pronounced in future deployment.
electronic prescriptions. The increased RR for ePrescrip-
tions was mainly due to one particular cause of interven- ePrescribing in Sweden, has been subject to a low degree
tion. Namely, the 'Dosage and directions for use'. The RR of governmental regulation. Nevertheless, the technical
for this cause compared to other causes of intervention standards have been mutually agreed by all actors on a
was 7.6 (95% CI 2.8–20.4) (Table 2). national level. A need for more detailed standards has
been recognized, resulting in the implementation of a
standardized new ePrescription format (NEF). Also, a
Table 1: Number (percentage) of prescriptions dispensed during the study period (three weeks in February 2006).
Only ordinary drug prescriptions dispensed for humans are included. Monthly statistics are adjusted (15/20) for the three week period.
Source: Apoteket AB Sweden
Page 4 of 8
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
Table 2: Causes of clarification contacts, presented according to type of prescription, in three mail-order pharmacies over a three
week period.
All prescriptions Refill prescriptions New ePrescriptions New non-electronic Relative risk
(N = 31225) (N = 16860) (N = 7532) prescriptions (95% CI)
(N = 6833)
Incorrect or incomplete
prescribing
Drug, strength, dosage form 45 10 15 20 0.5 (0.3–0.9)
Dosage and directions for use 73 21 48 4 7.6 (2.8–20.4)
Quantity or duration of therapy 21 5 8 8 0.6 (0.3–1.6)
Other 39 8 14 17 0.5 (0.3–1.0)
Prescriber, patient, or discount 23 2 7 14 0.3 (0.1–0.8)
information
Interactions
Drug-drug 6 3 2 1 1.3 (0.1–13.8)
Other causes
Adverse effects, toxicity, 44 16 17 11 1.0 (0.5–2.0)
illegible prescription, falsified
prescription, patients'
concerns, missing date, or
other
Drug temporarily unavailable or 97 38 39 20 1.2 (0.8–2.0)
withdrawn from the market
national working party for modernization of ePrescribing The majority of the pharmacists' clarification contacts
(MER) is developing next-generation applications. Some were accepted by the prescribers, which is in accordance
of the weaknesses in the ePrescribing process detected in with other studies [28]. This result emphasizes the bene-
the present study are expected to be improved with these fits of pharmacists as gatekeepers. It also underlines the
new standards. The introduction of an extensive electronic ongoing need for pharmacists to act in this area in order
process in health care involves a variety of different actors, to prevent the patient from incurring prescription errors.
emphasizing the need for a national infrastructure for If undiscovered, such errors may result in serious adverse
continuous change management, including strategies, drug reactions and even hospitalization [29,30]. On the
policies, and implementation for improved quality and other hand, there is an obvious benefit of designing the
safety. different EHRs to minimize primary errors. Such a strategy
would also reduce the need for pharmacist intervention.
Type of clarification contact All prescriptions Refill prescriptions New ePrescriptions New non-electronic prescriptions
Number (N = 312) % (N = 86) % (N = 147) % (N = 79) %
Page 5 of 8
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
Page 6 of 8
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
Competing interests 12. Åstrand B: Doctor's use of VDUs for medical prescriptions. In
Human-Computer Communications in Health Care Proceedings of the IFIP-
At the time of the study, two of the authors (BÅ, AE) were IMIA Second Stockholm Conference on Communication in Health Care
employed by Apoteket AB, a corporation fully owned by Edited by: Peterson HE, Schneider W. Stockholm, Sweden: Elsevier
the Swedish government to run all Swedish pharmacies, Science Publishers B.V; 1985:267-269.
13. Nilsson S, Ockander L, Dolby J, Åstrand B: A computer in the phy-
including MOPs. The eHealth institute, University of sician's consultancy. In MEDINFO 83 Proceedings of the Fourth
Kalmar is partly funded by Apoteket AB. Apoteket AB is World Conference on Medical Informatics Edited by: van Bemmel J, Ball
also obliged by the Swedish government to provide sales M, Wigertz O. Amsterdam: IFIP-IMIA, North-Holland Pub.Co;
1983:1185-1186.
statistics for the Swedish pharmaceutical market. 14. Nilsson S, Dolby J, Ockander L, Åstrand B: [Computer terminal in
the physician's office to assist drug prescription] In Swedish:
Dataterminal på läkarexpeditionen hjälp vid läkemedelsför-
Authors' contributions skrivningen. Lakartidningen 1982, 79:760-762.
BÅ was responsible for the analysis and the draft of the 15. Åstrand B: ePrescribing – Studies in Pharmacoinformatics.
manuscript. EM carried out the data analysis and partici- 2007 [http://urn.kb.se/resolve?urn=urn:nbn:se:hik:diva-32]. Kalmar:
University of Kalmar, Sweden
pated in the drafting of the manuscript. GP participated in 16. Åstrand B, Hovstadius B: [ePrescribing] In Swedish: Elektronisk
the analysis and the revision of the manuscript. AE con- recepthantering. In Läkemedelsboken Edited by: Bogentoft S. Stock-
holm: Apoteket AB; 2007:1196-1198.
ceived the study, participated in the design and coordina- 17. Sjoborg B, Backstrom T, Arvidsson LB, Andersen-Karlsson E, Blomb-
tion of the study and supervised the draft of the erg LB, Eiermann B, Eliasson M, Henriksson K, Jacobsson L, Jacobsson
manuscript. All authors read and approved the final man- U, Julander M, Kaiser PO, Landberg C, Larsson J, Molin B, Gustafsson
LL: Design and implementation of a point-of-care computer-
uscript. ized system for drug therapy in Stockholm metropolitan
health region-Bridging the gap between knowledge and
practice. Int J Med Inform 2007, 76:497-506.
Additional material 18. Kristensen N: [Danish pharmacies have a safe and quick elec-
tronic service] In Danish: Danske apoteker har en sikker og
hurtig e-handelslosning. Ugeskr Laeger 2005, 167:1546.
Additional file 1 19. Grimsmo A: [Electronic prescriptions–without side-effects?]
Protocol form translated to English In Norwegian: Elektronisk resept–uten bivirkninger? Tidsskr
Click here for file Nor Laegeforen 2006, 126:1740-1743.
20. Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE,
[http://www.biomedcentral.com/content/supplementary/1472- Strom BL: Role of computerized physician order entry sys-
6947-9-8-S1.doc] tems in facilitating medication errors. Jama 2005,
293:1197-1203.
21. Åstrand B, Hovstadius B, Antonov K, Petersson G: The Swedish
National Pharmacy Register. Stud Health Technol Inform 2007,
129:345-349.
Acknowledgements 22. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olaus-
We are indebted to pharmacy students Mary-Margaret Gabrielsson, Sara son P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M:
The new Swedish Prescribed Drug Register-Opportunities
Törngren, Therese Palo, Erika Wennstig-Johansson, and Lena Öhlund for for pharmacoepidemiological research and experience from
conducting the observational studies. As well, to pharmacy managers the first six months. Pharmacoepidemiol Drug Saf 2007, 16:726-735.
Yvonne Cloth, Bo Jeppsson, and Bengt-Åke Sundelin and their staff. Finally, 23. Feifer RA, Nevins LM, McGuigan KA, Paul L, Lee J: Mail-order pre-
to Britt-Marie Alsén for providing the statistical data and to Dr Elizabeth scriptions requiring clarification contact with the prescriber:
prevalence, reasons, and implications. J Manag Care Pharm
Hanson for valuable language advices. 2003, 9:346-352.
24. Chrischilles EA, Fulda TR, Byrns PJ, Winckler SC, Rupp MT, Chui MA:
References The role of pharmacy computer systems in preventing med-
1. Bates DW, Cohen M, Leape LL, Overhage JM, Shabot MM, Sheridan ication errors. J Am Pharm Assoc (Wash) 2002, 42:439-448.
T: Reducing the frequency of errors in medicine using infor- 25. Fulda TR, Lyles A, Pugh MC, Christensen DB: Current status of
mation technology. J Am Med Inform Assoc 2001, 8:299-308. prospective drug utilization review. J Manag Care Pharm 2004,
2. Corley ST: Electronic prescribing: a review of costs and bene- 10:433-441.
fits. Top Health Inf Manage 2003, 24:29-38. 26. Haavik S, Horn AM, Mellbye KS, Kjonniksen I, Granas AG: [Pre-
3. Cornell S: Electronic prescribing. New technology can reduce scription errors – dimension and measures] In Norwegian:
errors and save time. Adv Nurse Pract 2001, 9:107-108. Forskrivningsfeil – omfang og oppklaring. Tidsskr Nor Laege-
4. Halamka J: Early experiences with E-prescribing. J Healthc Inf foren 2006, 126:296-298.
Manag 2006, 20:12-14. 27. Kennedy AG, Littenberg B: A dictation system for reporting
5. Kohli M, Cook BG: Electronic prescribing at Johns Hopkins prescribing errors in community pharmacies. International
Community Physicians: a success story. Md Med 2005, 6:23-25. Journal of Pharmacy Practice 2004, 12:13-19.
6. Peterson C: On-line prescribing: keystrokes for quality. HMO 28. Carroll NV: Do community pharmacists influence prescrib-
1995, 36(5):11-14. ing? J Am Pharm Assoc 2003, 43:612-621.
7. Schiff GD, Rucker TD: Computerized prescribing: building the 29. Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, Wahlin A,
electronic infrastructure for better medication usage. Jama Dahlqvist R: Adverse drug reactions as a cause for admissions
1998, 279:1024-1029. to a department of internal medicine. Pharmacoepidemiol Drug
8. Schneck LH: E-prescribing can be new tool in quality-care Saf 2002, 11:65-72.
arsenal. MGMA Connex 2006, 6:32-37. 30. Knapp KK, Katzman H, Hambright JS, Albrant DH: Community
9. Tanne JH: Electronic prescribing could save at least 29bn dol- pharmacist interventions in a capitated pharmacy benefit
lars. Bmj 2004, 328:1155. contract. Am J Health Syst Pharm 1998, 55:1141-1145.
10. Venot A: Electronic prescribing for the elderly: will it improve 31. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H: Clinical phar-
medication usage? Drugs Aging 1999, 15:77-80. macy interventions by community pharmacists during the
11. Griffin JP: Venetian treacle and the foundation of medicines dispensing process. Br J Clin Pharmacol 1999, 47:695-700.
regulation. Br J Clin Pharmacol 2004, 58:317-325. 32. Buurma H, de Smet PA, Hoff OP van den, Egberts AC: Nature, fre-
quency and determinants of prescription modifications in
Page 7 of 8
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6947/9/8/prepub
Page 8 of 8
(page number not for citation purposes)